IL21582A - Compositions for the treatment of gout comprising a substituted 3-indolyl-carboxylic acid derivative - Google Patents

Compositions for the treatment of gout comprising a substituted 3-indolyl-carboxylic acid derivative

Info

Publication number
IL21582A
IL21582A IL2158264A IL2158264A IL21582A IL 21582 A IL21582 A IL 21582A IL 2158264 A IL2158264 A IL 2158264A IL 2158264 A IL2158264 A IL 2158264A IL 21582 A IL21582 A IL 21582A
Authority
IL
Israel
Prior art keywords
gout
indolyl
substituted
compositions
treatment
Prior art date
Application number
IL2158264A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL21582A publication Critical patent/IL21582A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/281-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL2158264A 1963-07-15 1964-06-23 Compositions for the treatment of gout comprising a substituted 3-indolyl-carboxylic acid derivative IL21582A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29518763A 1963-07-15 1963-07-15

Publications (1)

Publication Number Publication Date
IL21582A true IL21582A (en) 1968-08-22

Family

ID=23136613

Family Applications (1)

Application Number Title Priority Date Filing Date
IL2158264A IL21582A (en) 1963-07-15 1964-06-23 Compositions for the treatment of gout comprising a substituted 3-indolyl-carboxylic acid derivative

Country Status (5)

Country Link
BE (1) BE650350A (xx)
FR (1) FR4143M (xx)
GB (1) GB1072771A (xx)
IL (1) IL21582A (xx)
NL (4) NL6408031A (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001051489A2 (en) * 2000-01-14 2001-07-19 The Institutes For Pharmaceutical Discovery, Llc Methods for lowering uric acid levels
US11116737B1 (en) * 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Also Published As

Publication number Publication date
BE650350A (fr) 1965-01-11
NL6408031A (xx) 1965-01-18
GB1072771A (en) 1967-06-21
NL7008875A (xx) 1970-10-26
NL7008877A (xx) 1970-10-26
FR4143M (xx) 1966-05-09
NL7008876A (xx) 1970-10-26

Similar Documents

Publication Publication Date Title
MY6700062A (en) Ester of 6,7-di-substituted-4-hydroxy-3-quinolinecarboxylic acid
IL23530A (en) Process for the preparation of transchrysanthemumic acid
CY435A (en) Coumaranyl-n-methyl-carbamic acid esters
IL21582A (en) Compositions for the treatment of gout comprising a substituted 3-indolyl-carboxylic acid derivative
IL21692A (en) Derivatives of alpha-alkylidene-sulfonylphenoxyacetic acid
MY6800009A (en) Antibacterial derivative of t-aminocephalosporanic acid
FI47097C (fi) Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-metyyli-5 -metoksi-3-indolyylietikkahapon valmistamiseksi.
IL24190A (en) Crystallizing monochloroacetic acid
MY7100084A (en) Herbicidal compositions
MY6500036A (en) Amino-trichloropicolinic acid compounds
IE27252L (en) Adamantylthio-carboxylic acid derivatives
IE28004L (en) 7-aminocephalsporanic acid derivatives
IE28003L (en) 7-aminocephalosporanic acid derivative
FI43312C (fi) Menetelmä trans-4-aminometyylisykloheksaani-1-karbonihapon valmistamiseksi
IE27079L (en) Thiophosphorylacetic acid derivative
CA981273A (en) Lead compounds of 4:6-dinitroresorcinol
MY6900043A (en) Herbicidal compositions
IL24599A (en) 7-coumaranyl-n-methyl-carbamic acid esters
CA655676A (en) Epoxy acid compounds
AU287327B2 (en) Derivatives of 7-aminocephalos-poranic acid
CA669056A (en) Derivatives of alkoxy-benzoic acid
CA672479A (en) Gibberellic acid compositions
CA662692A (en) Anthranilic acid compounds
CA660316A (en) Anthranilic acid compounds
CA660315A (en) Anthranilic acid compounds